SENTRX - PRWeb Press Release Account Feed http://www.rsspad.com/rss2a/85032.xml SENTRX - Press Releases en xml@emediawire.com xml@emediawire.com 30 Sentrx Announces a Fast Start to 2008: Drug Safety Firm Gains Five New Clients in First Quarter http://www.prweb.com/releases/2008/04/prweb894374.htm Sentrx announced today that the company signed five new multi-year contracts for drug safety monitoring and safety system hosting in the first quarter of 2008. Sentrx now has more than thirty active clients. (PRWeb Apr 29, 2008)

Read the full story at http://www.prweb.com/releases/2008/04/prweb894374.htm

]]> http://www.prweb.com/releases/2008/04/prweb894374.htm Sentrx Announces New Director of Quality Standards http://www.prweb.com/releases/Sentrx/Metzler/prweb567799.htm Sentrx announced today that Christopher Metzler, DPM, has joined the firm as Director of Quality Standards. Dr. Metzler has extensive experience in global pharmacovigilance and drug information systems compliance and auditing. He will be responsible for the regulated document system; process improvement initiatives; and responses to client, health authority and business partner audits. (PRWeb Nov 12, 2007)

Read the full story at http://www.prweb.com/releases/Sentrx/Metzler/prweb567799.htm

]]> http://www.prweb.com/releases/Sentrx/Metzler/prweb567799.htm Sentrx to Participate in HIMSS'07 Interoperability Showcase http://www.prweb.com/releases/2007/02/prweb505807.htm Sentrx announced today that it is an implementer in an interoperability scenario to be demonstrated at HIMSS'07. Sentrx is contributing its expertise in drug safety data and pharmacovigilance systems to help demonstrate a patient-reported adverse event transferring from the physician's practice system to the pharmaceutical company's safety system using industry standards. (PRWeb Feb 21, 2007)

Read the full story at http://www.prweb.com/releases/2007/02/prweb505807.htm

]]> http://www.prweb.com/releases/2007/02/prweb505807.htm Sentrx Exits 2006 Doubling Its Contracts http://www.prweb.com/releases/2007/01/prweb495527.htm Sentrx announced today that in 2006 it doubled the number of biopharmaceutical companies it serves. The drug safety specialty firm gained eleven new clients, renewed contracts with several long-term clients, and expanded the scope of services provided to others. (PRWeb Jan 8, 2007)

Read the full story at http://www.prweb.com/releases/2007/01/prweb495527.htm

]]> http://www.prweb.com/releases/2007/01/prweb495527.htm Sentrx Expands Business Development and Client Relations http://www.prweb.com/releases/2006/07/prweb415111.htm Sentrx announced today that three proven pharmaceutical-industry leaders have joined the company in Business Development and Client Relations positions. Richard Onorato, MBA; Frank McCabe, RPh, MBA; and Amy Zastaway, RN, MPH each have more that 20 years of healthcare industry experience and will help support the growing number of clients Sentrx serves and the high level of interest in its pharmacovigilance offerings. (PRWeb Jul 25, 2006)

Read the full story at http://www.prweb.com/releases/2006/07/prweb415111.htm

]]> http://www.prweb.com/releases/2006/07/prweb415111.htm Sentrx Receives Additional Investment http://www.prweb.com/releases/2006/06/prweb396062.htm Sentrx, the leading provider of drug safety services, announced today that it closed a new round of financing. The investment by Argosy Partners and Edison Venture Fund will be used to enhance information technology, increase sales and marketing activities, and expand client support. (PRWeb Jun 8, 2006)

Read the full story at http://www.prweb.com/releases/2006/06/prweb396062.htm

]]> http://www.prweb.com/releases/2006/06/prweb396062.htm Sentrx Announces New Director of Pharmacovigilance Operations http://www.prweb.com/releases/2006/05/prweb382976.htm Sentrx announced today that Suzanne Tepper, PharmD, RPh, has joined the firm as Director of Pharmacovigilance Operations. Dr. Tepper held drug safety management positions at Aventis, Johnson & Johnson, and Schering-Plough. She will be responsible for the people, processes and technology associated with the intake and investigation of adverse event cases. (PRWeb May 10, 2006)

Read the full story at http://www.prweb.com/releases/2006/05/prweb382976.htm

]]> http://www.prweb.com/releases/2006/05/prweb382976.htm Sentrx Announces Partnership with Thomson Scientific: Drug Safety Firm will Incorporate Leading-Edge Literature Search Capabilities into Service Offerings http://www.prweb.com/releases/2005/04/prweb226929.htm Sentrx announced today that it has signed an agreement with Thomson Scientific’s Custom Information ServicesSM group to deliver customized literature searches for adverse events. Sentrx will offer these capabilities as part of its Value-Added Services. (PRWeb Apr 11, 2005)

Read the full story at http://www.prweb.com/releases/2005/04/prweb226929.htm

]]> http://www.prweb.com/releases/2005/04/prweb226929.htm Sentrx Goes Live with Electronic Submissions to FDA: Drug Safety Firm Approved for Adverse Event Case Reporting Through ESTRI Gateway http://www.prweb.com/releases/2005/04/prweb224069.htm Sentrx announced today that it has successfully completed its electronic submissions pilot with the U.S. Food and Drug Administration (FDA). Reporting of Individual Case Safety Reports (ICSRs) is now in production through the FDA ESTRI Gateway on behalf of one of Sentrx’s clients, a Top 50 pharmaceutical company. Sentrx has initiated a similar approval process with the European Agency for the Evaluation of Medicinal Products (EMEA). (PRWeb Apr 4, 2005)

Read the full story at http://www.prweb.com/releases/2005/04/prweb224069.htm

]]> http://www.prweb.com/releases/2005/04/prweb224069.htm Sentrx and Taratec Announce New Annual Pharmacovigilance Audit Service http://www.prweb.com/releases/2005/01/prweb197916.htm Sentrx and Taratec announced today a new offering designed to help life science companies understand and document their compliance with pharmacovigilance laws, regulations, and guidances. The Annual Pharmacovigilance Audit will evaluate the processes and systems related to adverse event reporting, document where Good Pharmacovigilance Practices are being followed, and recommend remedial action if necessary. It will help biopharmaceutical companies demonstrate a dedication to patient safety. (PRWeb Jan 18, 2005)

Read the full story at http://www.prweb.com/releases/2005/01/prweb197916.htm

]]> http://www.prweb.com/releases/2005/01/prweb197916.htm New Sentrx Website Earns Silver Spotlight Award: Sentrx and Kurani Interactive Recognized by League of American Communications Professionals http://www.prweb.com/releases/2004/11/prweb180908.htm Sentrx and Kurani Interactive announced today that they won Silver in the 2004 Spotlight Print, Video and Web PR Competition sponsored by the League of American Communications Professionals (LACP). The New Sentrx Website entry ranked third out of 29 in the Website/Intranet Category for companies with revenues between $10 and 100 million. (PRWeb Nov 22, 2004)

Read the full story at http://www.prweb.com/releases/2004/11/prweb180908.htm

]]> http://www.prweb.com/releases/2004/11/prweb180908.htm